期刊文献+

探讨支气管哮喘患者的临床护理体会 被引量:1

Discussion bronchial tube asthma patient's clinical nursing experience
原文传递
导出
摘要 支气管哮喘(简称哮喘)是常见的呼吸系疾病,其发病率及患病率不断上升,在我国约有1500万~2000万人罹患哮喘.哮喘在我国的发病率约为1%~2%,是严重影响人们健康的常见病.老年哮喘是指60岁以后新发的支气管哮喘及60岁以前发病延至老年者,老年哮喘被认为是哮喘发病的第二高峰,发病率仅次于儿童哮喘.老年哮喘以内源性哮喘多见,感染为最主要诱因.由于老年体弱,基础病多,哮喘发作严重,并发症发生率高,药物治疗反应差. Bronchial tube asthma (i. e. asthma) is the common breath is disease,its disease incidence rate and the prevalence rate rise unceasingly,has 15,000,000 - 20,000,000 people in our country to suffer from asthma approximately. Asthma in our country's disease incidence rate is approximately 1 %- 20%,is affects the people health seriously common disease. Old age asthma was refers to the bronchial tube asthma and 60 year old of before which 60 year old of later will send newly was taken bad delays until the old age, old age asthma was considered was the asthma morbidity second peak, the disease incidence rate is only inferior to the child asthma. Old age asthma sees take the endocardial asthma, infects as the most main cause. Because the old age is physically weak, the foundation gets sick much, asthma outbreak is serious, the complication formation rate is high, the medicine treats the counter-- differential.
出处 《按摩与康复医学》 2011年第3期158-158,共1页 Chinese Manipulation and Rehabilitation Medicine
关键词 支气管哮喘 临床护理 体会 Bronehiat tube asthma Clinical nursing Experience
  • 相关文献

参考文献4

二级参考文献11

  • 1Barnes PJ. Scientific rationale for inhaled combination therapy with long-acting beta2-agonists and corticosteroids. Eur Respir J, 2002,19:182-191.
  • 2Campbell LM. From adrenaline to formoterol: advances in beta-agonist therapy in the treatment of asthma. Int J Clin Pract, 2002,56: 783-790.
  • 3Rees PJ. Tiotropium in the management of chronic obstructive pulmonary disease. Eur Respir J, 2002,19: 205-206.
  • 4Hansel TT, Barnes PJ. Novel drugs for treating asthma. Curr Allergy Asthma Rep, 2001,1: 164-173.
  • 5Owen CE. Anti-immunoglobulin E therapy for asthma. Pulm Pharmacol & Ther, 2002,15: 417-424.
  • 6Hansel TT. New treatments for asthma: current and future aspects. Curr Opin Pulm Med, 2001,7 Suppl 1:S3-S6.
  • 7Andre C, Vatrinet C, Galvain S, et al. Safety of sublingual-swallow immunotherapy in children and adults. Int Arch Allergy Immunol, 2000, 121: 229-234.
  • 8郭雪君 见: 黄绍光 主编.哮喘的基因治疗[A].见: 黄绍光,主编.肺内科新进展[C].北京:人民卫生出版社,2000.94-101.
  • 9沈华浩,朱元珏.哮喘免疫治疗的新进展[J].中华结核和呼吸杂志,2000,23(1):55-56. 被引量:39
  • 10郭克泰.过敏原免疫疗法的现状[J].国外医学(呼吸系统分册),2001,21(3):157-160. 被引量:1

共引文献3603

同被引文献5

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部